(CNQ) Canadian Natural Resources - Overview
Sector: EnergyIndustry: Oil & Gas E&P | Exchange NYSE (USA) | Currency USD | Market Cap: 104.486m | Total Return 70.6% in 12m
Stock: Crude Oil, Natural Gas, Liquids
| Risk 5d forecast | |
|---|---|
| Volatility | 27.7% |
| Relative Tail Risk | 3.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.72 |
| Alpha | 59.05 |
| Character TTM | |
|---|---|
| Beta | 0.545 |
| Beta Downside | 0.681 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.85% |
| CAGR/Max DD | 0.78 |
EPS (Earnings per Share)
Revenue
Description: CNQ Canadian Natural Resources March 05, 2026
Canadian Natural Resources Limited (CNQ) explores, develops, and produces crude oil, natural gas, and natural gas liquids (NGLs).
Operations span Western Canada, the UK North Sea, and Offshore Africa. The companys product portfolio includes various crude oil types: light, medium, primary heavy, Pelican Lake heavy, bitumen, and synthetic crude oil. CNQ also holds midstream assets, including two crude oil pipeline systems. The energy sector frequently utilizes such infrastructure to transport extracted resources.
Additionally, CNQ owns a 50% interest in an 84-megawatt cogeneration plant at Primrose. Cogeneration plants improve energy efficiency by producing both electricity and useful heat. For further analysis, consider exploring CNQs financial performance and operational metrics on ValueRay.
The company, incorporated in 1973 as AEX Minerals Corporation, adopted its current name in 1975 and is headquartered in Calgary, Canada.
Headlines to watch out for
- Global crude oil prices dictate revenue and profitability
- Natural gas demand and pricing impact earnings
- Regulatory changes to carbon emissions affect operations
- Production costs for oil sands influence margins
- Geopolitical stability in operating regions impacts output
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 10.82b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -0.40 > 1.0 |
| NWC/Revenue: -0.96% < 20% (prev -5.36%; Δ 4.40% < -1%) |
| CFO/TA 0.16 > 3% & CFO 15.10b > Net Income 10.82b |
| Net Debt (19.03b) to EBITDA (18.36b): 1.04 < 3 |
| Current Ratio: 0.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.09b) vs 12m ago -1.47% < -2% |
| Gross Margin: 30.13% > 18% (prev 0.26%; Δ 2.99k% > 0.5%) |
| Asset Turnover: 46.87% > 50% (prev 48.63%; Δ -1.76% > 0%) |
| Interest Coverage Ratio: 10.52 > 6 (EBITDA TTM 18.36b / Interest Expense TTM 833.8m) |
Altman Z'' 2.78
| A: -0.00 (Total Current Assets 7.66b - Total Current Liabilities 8.06b) / Total Assets 91.76b |
| B: 0.36 (Retained Earnings 32.70b / Total Assets 91.76b) |
| C: 0.10 (EBIT TTM 8.77b / Avg Total Assets 88.56b) |
| D: 0.93 (Book Value of Equity 44.33b / Total Liabilities 47.43b) |
| Altman-Z'' Score: 2.78 = A |
Beneish M -0.68
| DSRI: 0.97 (Receivables 4.00b/4.13b, Revenue 41.50b/41.51b) |
| GMI: 0.87 (GM 30.13% / 26.25%) |
| AQI: 5.28 (AQ_t 0.04 / AQ_t-1 0.01) |
| SGI: 1.00 (Revenue 41.50b / 41.51b) |
| TATA: -0.05 (NI 10.82b - CFO 15.10b) / TA 91.76b) |
| Beneish M-Score: -0.68 (Cap -4..+1) = D |
What is the price of CNQ shares?
Over the past week, the price has changed by +3.53%, over one month by +15.48%, over three months by +52.34% and over the past year by +70.63%.
Is CNQ a buy, sell or hold?
- StrongBuy: 8
- Buy: 6
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CNQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 43.5 | -13.2% |
| Analysts Target Price | 43.5 | -13.2% |
CNQ Fundamental Data Overview March 28, 2026
P/E Trailing = 13.3573
P/E Forward = 23.0947
P/S = 2.6956
P/B = 3.1485
P/EG = 3.4186
Revenue TTM = 41.50b CAD
EBIT TTM = 8.77b CAD
EBITDA TTM = 18.36b CAD
Long Term Debt = 16.18b CAD (from longTermDebt, last quarter)
Short Term Debt = 813.3m CAD (from shortTermDebt, last quarter)
Debt = 19.71b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.03b CAD (from netDebt column, last quarter)
Enterprise Value = 164.19b CAD (145.15b + Debt 19.71b - CCE 672.5m)
Interest Coverage Ratio = 10.52 (Ebit TTM 8.77b / Interest Expense TTM 833.8m)
EV/FCF = 19.75x (Enterprise Value 164.19b / FCF TTM 8.31b)
FCF Yield = 5.06% (FCF TTM 8.31b / Enterprise Value 164.19b)
FCF Margin = 20.03% (FCF TTM 8.31b / Revenue TTM 41.50b)
Net Margin = 26.06% (Net Income TTM 10.82b / Revenue TTM 41.50b)
Gross Margin = 30.13% ((Revenue TTM 41.50b - Cost of Revenue TTM 29.00b) / Revenue TTM)
Gross Margin QoQ = 21.20% (prev 48.39%)
Tobins Q-Ratio = 1.79 (Enterprise Value 164.19b / Total Assets 91.76b)
Interest Expense / Debt = 1.24% (Interest Expense 244.8m / Debt 19.71b)
Taxrate = 22.56% (1.54b / 6.84b)
NOPAT = 6.79b (EBIT 8.77b * (1 - 22.56%))
Current Ratio = 0.95 (Total Current Assets 7.66b / Total Current Liabilities 8.06b)
Debt / Equity = 0.44 (Debt 19.71b / totalStockholderEquity, last quarter 44.33b)
Debt / EBITDA = 1.04 (Net Debt 19.03b / EBITDA 18.36b)
Debt / FCF = 2.29 (Net Debt 19.03b / FCF TTM 8.31b)
Total Stockholder Equity = 41.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.21% (Net Income 10.82b / Total Assets 91.76b)
RoE = 25.98% (Net Income TTM 10.82b / Total Stockholder Equity 41.63b)
RoCE = 15.18% (EBIT 8.77b / Capital Employed (Equity 41.63b + L.T.Debt 16.18b))
RoIC = 11.57% (NOPAT 6.79b / Invested Capital 58.74b)
WACC = 7.07% (E(145.15b)/V(164.86b) * Re(7.90%) + D(19.71b)/V(164.86b) * Rd(1.24%) * (1-Tc(0.23)))
Discount Rate = 7.90% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -2.10%
[DCF] Terminal Value 81.92% ; FCFF base≈8.22b ; Y1≈8.16b ; Y5≈8.53b
[DCF] Fair Price = 80.63 (EV 187.23b - Net Debt 19.03b = Equity 168.19b / Shares 2.09b; r=7.07% [WACC]; 5y FCF grow -1.45% → 3.0% )
EPS Correlation: -87.00 | EPS CAGR: -28.33% | SUE: 1.99 | # QB: 1
Revenue Correlation: -27.79 | Revenue CAGR: -6.05% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.42 | Chg7d=+0.440 | Chg30d=+0.851 | Revisions Net=+1 | Analysts=4
EPS current Year (2026-12-31): EPS=3.43 | Chg7d=+0.373 | Chg30d=+0.722 | Revisions Net=+4 | Growth EPS=-3.5% | Growth Revenue=-7.1%
EPS next Year (2027-12-31): EPS=3.64 | Chg7d=+0.227 | Chg30d=+0.224 | Revisions Net=-1 | Growth EPS=+6.1% | Growth Revenue=+3.3%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.4% (Discount Rate 7.9% - Earnings Yield 7.5%)
[Growth] Growth Spread = +8.5% (Analyst 8.9% - Implied 0.4%)